CWA
VRTX icon

Carolina Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Carolina Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.97K Hold
10
– – ﹤0.01% 239
2026
Q1 		$4.46K Hold
10
– – ﹤0.01% 235
2025
Q4 		$4.53K Hold
10
– – ﹤0.01% 208
2025
Q3 		$3.92K Sell
10
-5
-33% -$2.09K ﹤0.01% 195
2025
Q2 		$6.68K Hold
15
– – ﹤0.01% 168
2025
Q1 		$7.27K Hold
15
– – ﹤0.01% 156
2024
Q4 		$6.04K Hold
15
– – ﹤0.01% 179
2024
Q3 		$6.98K Buy
+15
New +$7.21K ﹤0.01% 194
2021
Q2 		– Sell
-7
Closed -$2K – 319
2021
Q1 		$2K Hold
7
– – ﹤0.01% 285
2020
Q4 		$2K Hold
7
– – ﹤0.01% 223
2020
Q3 		$2K Buy
+7
New +$1.93K ﹤0.01% 203

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Carolina Wealth Advisors's VRTX Position: Q2 2026 in Review

Carolina Wealth Advisors held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 10 shares worth $4.97K. The position accounts for ﹤0.01% of the portfolio, ranked #239.

Carolina Wealth Advisors first reported a position in VRTX in Q3 2020 and has held it in 11 quarters since. The position peaked at $7.27K in Q1 2025. 252 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Carolina Wealth Advisors held 10 shares of Vertex Pharmaceuticals worth $4.97K as of Q2 2026.
  • Carolina Wealth Advisors left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Carolina Wealth Advisors's portfolio in Q2 2026, its #239 holding.
  • Carolina Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 11 quarters since.
  • Carolina Wealth Advisors's Vertex Pharmaceuticals position peaked at $7.27K in Q1 2025.
  • 252 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Carolina Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.